Ether

Ether

SCHEMBL422163

CCOCC.CO.ClC(Cl)Cl

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.32
THRB P10828 1/20 0.32
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL9087672 0.94 ALDH1A1 (0.36) ALDH1A1
Ether SCHEMBL2837591 0.93 ALDH1A1 (0.37) ALDH1A1THRBLMNA
Ether SCHEMBL96502 0.93
Ether SCHEMBL8089271 0.93 ALDH1A1 (0.37) ALDH1A1THRBLMNA
Ether SCHEMBL3794585 0.93 ALDH1A1 (0.37) ALDH1A1THRBLMNA
Ether SCHEMBL3701280 0.93 ALDH1A1 (0.37) ALDH1A1THRBLMNA
Ether SCHEMBL4944310 0.90 ALDH1A1 (0.45) ALDH1A1TSHRTHRB
Hexane SCHEMBL10432593 0.88 TSHR (0.37) ALDH1A1TSHRTHRBLMNA
Ether SCHEMBL28705136 0.86
Ether SCHEMBL28734827 0.86 ALDH1A1 (0.33) ALDH1A1THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12036294-B2 Spherical rHDLs for targeted imaging SIGNABLOK, INC. (US) 2024-07-16 US disclosed
US-20240182463-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG SHIONOGI & CO., LTD. (JP) 2024-06-06 US disclosed
US-20210205485-A1 Spherical rHDLs For Targeted Imaging SIGNABLOK, INC. 2021-07-08 US disclosed
US-10894098-B2 Methods and compositions for targeted imaging SIGNABLOK, INC. (US) 2021-01-19 US disclosed
US-20200339565-A1 PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2020-10-29 US disclosed
US-20200101178-A1 Methods And Compositions For Targeted Imaging SIGNABLOK, INC. 2020-04-02 US disclosed
US-20190248785-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG SHIONOGI & CO., LTD. (JP) 2019-08-15 US disclosed
US-10202379-B2 Substituted polycyclic carbamoyl pyridone derivative prodrug SHIONOGI & CO., LTD. (JP) 2019-02-12 US disclosed
EP-2620436-B1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG SHIONOGI & CO (JP) 2018-05-09 EP disclosed
EP-2444400-B1 SUBSTITUTED POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE SHIONOGI & CO (JP) 2018-03-28 EP disclosed
US-4866035-A Dipeptidyl saccharides as host resistance enhancers in AIDS-immuno-compromised hosts and methods of use MERCK & CO., INC. (US) 1989-09-12 US disclosed
EP-0266006-A2 Novel hypotensive diuretic peptides SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) 1988-05-04 EP disclosed
US-4672106-A ANTITUMOR AGENTS Hamaoka, Toshiyuki (JP) 1987-06-09 US disclosed
EP-0192611-A2 Acylated hexose derivatives and method for their preparation CIBA-GEIGY AG (CH) 1986-08-27 EP disclosed
EP-0173960-A2 Muramylpeptide active ester derivatives Hamaoka, Toshiyuki (JP) 1986-03-12 EP disclosed
EP-0163286-A2 Acylated sugars, method for their preparation and their use CIBA-GEIGY AG (CH) 1985-12-04 EP disclosed
US-4461763-A CARDIOTONIC AGENTS BOEHRINGER MANNHEIM GMBH (DE) 1984-07-24 US disclosed
US-4315031-A Thiosubstituted amino acids SCIENCE UNION ET CIE (FR) 1982-02-09 US disclosed
US-4304772-A Ethanocarbazole derivatives and antidepressant compositions AYERST, MCKENNA & HARRISON, INC. (CA) 1981-12-08 US disclosed
US-4107299-A Cardioactive 12-epi-digoxin and derivatives thereof BOEHRINGER MANNHEIM GMBH (DE) 1978-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240182463-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG PREP, UNG, DPP4 ALDH1A1 1564/4885TSHR 3454/4885THRB 3578/4885
US-20190248785-A1 SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG PREP, UNG, DPP4 ALDH1A1 1564/4885TSHR 3454/4885THRB 3578/4885
US-20200339565-A1 PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PREP, UNG, DPP4 ALDH1A1 1478/4885TSHR 3454/4885THRB 3501/4885
US-10202379-B2 Substituted polycyclic carbamoyl pyridone derivative prodrug PREP, UNG, DPP4 ALDH1A1 1564/4885TSHR 3454/4885THRB 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.